Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2010
02/18/2010WO2009128911A3 Genetics variants associated with hiv disease restriction
02/18/2010WO2009128272A4 Expression vector
02/18/2010WO2009126898A3 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus( (jev) and their use
02/18/2010WO2009126719A3 Commensal bacteria as signal mediators within a mammalian host
02/18/2010WO2009120763A3 Genetic polymorphisms and infertility
02/18/2010WO2009111572A3 Cell, method and kit for conducting an assay for neutralizing antibodies
02/18/2010WO2009108021A3 Biomarker for diagnosing hyperpigmentation of skin
02/18/2010WO2009083790A8 'apoptosis inducing positive control for expression modulating experiments'
02/18/2010WO2009037402A9 Hpiv-2 variants and medical applications thereof
02/18/2010WO2008109825A3 Inducing immune-mediated tumor cell death
02/18/2010WO2008080150A3 Reduction of polyalanine-induced protein aggregates and toxicity by ubiquilin
02/18/2010WO2008075364A3 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
02/18/2010WO2004084705A9 Quantitative detection of h. pylori in biological samples
02/18/2010US20100043105 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same
02/18/2010US20100043104 Application of fluorescent protein to garden plant
02/18/2010US20100043103 Process for the Production of Arachidonic Acid and/or Eicosapentaenoic Acid
02/18/2010US20100043102 Nematode Inducible Promotors and Methods of Use
02/18/2010US20100043101 Method for controlling root parasitic plants
02/18/2010US20100043100 Polynucleotides for regulation of high level tissue-preferred expression in crop plants
02/18/2010US20100043099 Expression control elements from the lemnaceae family
02/18/2010US20100043098 Plant raffinose saccharide biosynthetic enzymes
02/18/2010US20100043097 Brassinosteroid Regulated Kinases (BRKs) That Mediate Brassinosteroid Signal Transduction and Uses Thereof
02/18/2010US20100043096 The Method for Enhancement of Photosynthesis and Biomass of Plant by Plastid Transformation of Malate Dehydrogenase
02/18/2010US20100043094 Soybean variety d5223512
02/18/2010US20100043093 Soybean variety d5824620
02/18/2010US20100043092 Soybean variety d5214244
02/18/2010US20100043091 Soybean variety d5336524
02/18/2010US20100043090 Soybean variety d5852641
02/18/2010US20100043089 Soybean variety d5638947
02/18/2010US20100043088 Soybean variety d5568543
02/18/2010US20100043087 Soybean variety d5234214
02/18/2010US20100043086 Soybean variety d5365424
02/18/2010US20100043085 Tomato Hybrid Annamay
02/18/2010US20100043083 Insect chemosensory receptors and methods of use thereof
02/18/2010US20100043082 Transgenic Frog Lines and Assays Employing Them
02/18/2010US20100041868 Conserved neisserial antigens
02/18/2010US20100041742 Riboswitches, methods for their use, and compositions for use with riboswitches
02/18/2010US20100041741 Suppression of mitochondrial oxidative stress
02/18/2010US20100041740 Flu vaccines and methods of use thereof
02/18/2010US20100041738 Hybridization-stabilizing construct
02/18/2010US20100041737 Gene Vector
02/18/2010US20100041733 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION
02/18/2010US20100041610 Insecticidal toxin complex fusion protiens
02/18/2010US20100041601 Use of VEGF and homologues to treat neuron disorders
02/18/2010US20100041596 Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor Receptors
02/18/2010US20100041595 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
02/18/2010US20100041569 Methods of using an array of pooled probes in genetic analysis
02/18/2010US20100041165 Probe-immobilized carrier storing manufacturing condition data and manufacturing method and apparatus thereof, detecting method of target substance by use of the probe-immobilized carrier, and measuring apparatus, recording medium, kit and system for use in the detecting method
02/18/2010US20100041153 Expression of Proteins in E. Coli
02/18/2010US20100041152 Methods for encapsulating plasmids in lipid bilayers
02/18/2010US20100041151 Compositions and methods for treating lysosomal storage disease
02/18/2010US20100041144 Mammalian Cytokine; Related Reagents
02/18/2010US20100041141 Methods and compositions relating to improved lentiviral vectors and their applications
02/18/2010US20100041140 Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof
02/18/2010US20100041139 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
02/18/2010US20100041138 IL-17 homologous polypeptides and therapeutic uses thereof
02/18/2010US20100041136 Connective Tissue Growth Factor-2
02/18/2010US20100041121 Metabolically engineered organisms for the production of hydrogen and hydrogenase
02/18/2010US20100041115 Whose genes coding for acyl-CoA oxidase were disrupted
02/18/2010US20100041113 Delta 6 desaturases and their use in making polyunsaturated fatty acids
02/18/2010US20100041108 Method for producing l-methionine by fermentation
02/18/2010US20100041107 Method of reducing gene expression using modified codon usage
02/18/2010US20100041103 Composition and method for enhancing cell growth and cell fusion
02/18/2010US20100041102 Antagonists of pcsk9
02/18/2010US20100041101 Expression system for recombinant human arginase i
02/18/2010US20100041100 modified Trichoderma reesei Family 6 (TrCel6A) cellulase more tolerant of lignin for use in enzymatic hydrolysis of cellulose in the presence of lignin, e.g., the hydrolysis of pretreated lignocellulosic feedstocks for the production of fermentable sugars, sugar alcohols and fuel alcohol
02/18/2010US20100041098 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
02/18/2010US20100041097 Synthetic gene control region
02/18/2010US20100041096 Carcinostatic method using BRCA1-BARD1 pathway
02/18/2010US20100041092 Drug controlled molecular tags
02/18/2010US20100041075 Tuberculosis Diagnostic Test
02/18/2010US20100041060 Iron-regulating protein-2(irp-2) as a diagnostic for neurodegenerative disease
02/18/2010US20100041054 Methods for the production of ips cells
02/18/2010US20100041047 Efficient reduction of target rna's by single- and double-stranded oligomeric compounds
02/18/2010US20100041035 Identification of centromere sequences and uses therefor
02/18/2010US20100041033 Site specific system for generating diversity protein sequences
02/18/2010US20100041028 Zinc finger binding domains for GNN
02/18/2010US20100041025 Compositons, methods and kits for real-time nucleic acid analysis in live cells
02/18/2010US20100041012 Rationally designed antibodies
02/18/2010US20100040754 Protein having sweetness
02/18/2010US20100040675 Compositions and methods for promoting or inhibiting angiogenesis
02/18/2010US20100040649 Inducible expression systems
02/18/2010US20100040648 Plasmids with immunological action
02/18/2010US20100040643 Flavivirus immunogens and methods of use
02/18/2010US20100040640 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
02/18/2010US20100040636 Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists
02/18/2010US20100040632 Composition
02/18/2010US20100040629 Antibodies to c-Met
02/18/2010US20100040627 Baff receptor (bcma), an immunoregulatory agent
02/18/2010US20100040624 Human Tumor Necrosis Factor TR21 and Methods Based Thereon
02/18/2010US20100040621 Novel polpeptide and use thereof
02/18/2010US20100040613 Polypeptide constructs for sublingual administration
02/18/2010US20100040611 Antagonists of pcsk9
02/18/2010US20100040610 Antagonists of pcsk9
02/18/2010US20100040606 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
02/18/2010US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
02/18/2010US20100040602 Antibodies against Human Cytimegalovirus (HCMV)
02/18/2010US20100040597 Thrombin mutant
02/18/2010US20100040590 Tumor-associated peptides binding to human leukocyte antigen (HLA) class II molecules
02/18/2010US20100040578 Malignant Tumor Cell Suppressor Protein, Malignant Tumor Cell Suppressor Gene, Maligant Tumor Cell Suppressive Viral Vector, and Kit Using the Same
1 ... 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 ... 4023